Pharmacology Week 1 3
Pharmacology Week 1 3
Pharmacology 1
Sean Juvan S. SyCip, MSN, RN
Introduction
2
Pharmacology
is the study of the biological effects of
chemicals.
Pharmacotherapeutics or clinical
pharmacology
- The branch of pharmacology
that uses drugs to treat,
prevent, and diagnose
disease.
3
Pharmacology
- 2 key concerns:
■ The drug’s effects on
the body
(pharmacokinetics)
■ And the body’s
response to the drug
(pharmacodynamics)
Adverse effects – negative or
undesirable effects of the drug.
4
Core Ethical Principles
5
“
Respect for Persons
▸ Patients should be treated as independent
persons who are capable of making
decisions in their own best interests.
Patients with diminished decision-making
capacity are entitled to protection.
6
Informed Consent
“
The two most relevant aspects of the Code are the right to
be informed and that participation is voluntary, without
coercion. If coercion is suspected, the nurse is obligated to
report this suspicion promptly. Informed consent has
dimensions beyond protection of the individual patient’s
choice:
• It is a mutual sharing of information, a process of
communication.
• It expresses respect for the person.
• It gains the patient’s active involvement in their care.
• It respects the patient’s right to self-determination.
7
Beneficence
“
Beneficence is the duty to protect research subjects from
harm. It involves assessing potential risks
and possible benefits and ensuring the benefits are
greater than the risk.
Justice
Justice requires that the selection of research subjects be
fair. Research must be conducted so that
the distribution of benefits and burdens is equitable (i.e.,
research subjects reflect all social classes
and racial and ethnic groups).
8
Sources of DRUGS 1
“
▸ Plants
▸ Animal products
- Genetic Engineering is the process of
altering DNA which permits scientists
to produce human insulin by altering
Escherichia coli bacteria, making
insulin a better product without some
of the impurities that come with
animal products.
10
“
▸ Inorganic Compounds
- Aluminum - to decrease gastric acidity,
management of hyperphosphatemia,
prevention of formation of phosphate
urinary stones
- Fluoride – prevention of dental cavities,
prevention of osteoporosis
- Gold – treatment of rheumatoid arthritis
- Iron – treatment of iron deficiency
anemia
11
Phases of Drug Development
Preclinical Trials
-Chemicals that may have therapeutic value are tested on laboratory animals
for two main purposes:
1. To determine whether they have the presumed effects in living tissue
2. To evaluate any adverse effects
-At the end of the preclinical trials, some chemicals are discarded for the
following reasons:
▹ The chemical lacks therapeutic activity when used with living animals
▹ The chemical are too toxic
▹ The chemical is highly teratogenic
▹ The safety margins are so small
12
Phase I studies
- Use human volunteers to test the drugs
- Volunteers are fully informed of possible risks and may be paid for
their participation.
At the end of phase I Studies, many chemicals are dropped from the
process for the following reasons:
▹ They lack therapeutic effect on humans
▹ They cause unacceptable adverse effects
▹ They are highly teratogenic
▹ They are too toxic
13
Phase II studies
- Allow clinical investigators to try the drug in patients who have the
disease that the drug is meant to treat.
At the end of phase II studies, a drug may be removed from further investigation
for the following reasons:
▹ It is less effective than anticipated
▹ It is too toxic when used with patients
▹ It produces unacceptable adverse effects
▹ It has low low benefit-to-risk ratio
▹ It is no more effective than other drugs already on the market, making the
cost of continued research and production less attractive to the drug
14 company
Phase III studies and Phase IV studies
15
FDA Pregnancy
Categories
16
Categories
Category A Category B
- Adequate studies in - Animal studies have not demonstrated a
pregnant women have risk to the fetus but there are no
adequate studies in pregnant women, or
not demonstrated a risk
animal studies have shown an adverse
to the fetus in the first effect, but adequate studies in pregnant
trimester of pregnancy, women have not demonstrated a risk to
and there is no evidence the fetus during the first trimester of
of risk in later trimesters pregnancy, and there is no evidence of
risk in later trimesters.
17
Categories
Category C Category D
- Animal studies have shown an - There is evidence of
adverse effect on the fetus but there human fetal risk, but the
are no adequate studies in the potential benefits from the
benefits from the use of the drug in use of the drug in pregnant
pregnant women may be acceptable women may be acceptable
despite its potential risks, or there despite its potential risks.
are no animal reproduction studies
and no adequate studies in humans.
18
Categories
Category X
- Studies in animals or humans demonstrates fetal abnormalities or
adverse reactions; reports indicate evidence of fetal risk. The risk of use
in a pregnant woman clearly outweighs any possible benefit.
19
Drug Enforcement Agency (DEA)
Schedules of Controlled
Substances
Schedule I (C-I)
- High abuse potential and
no accepted medical use
(heroin, marijuana, LSD –
Lysergic acid
Diethylamide)
20
Drug Enforcement Agency (DEA)
Schedules of Controlled
Substances
Schedule II (C-II)
- High abuse potential with
severe dependence
liability (narcotics,
amphetamines, and
barbiturates)
21
Drug Enforcement Agency (DEA)
Schedules of Controlled
Substances
Schedule IV (C-IV)
- Less abuse potential than
schedule III and limited
dependence liability (some
sedatives, antianxiety agents,
and non – narcotic
analgesics)
23
Drug Enforcement Agency (DEA)
Schedules of Controlled
Substances
Schedule V (C-V)
- Limited abuse potential.
Primarily small amounts of
narcotics (codeine) used as
antitussives or antidiarrheals.
24
!!!!!!!!!!!!!!!
25
!!!!!!!!
26
!!!!!!
27
Use diagrams to explain your ideas
28
Over – the – counter
drugs
OTC – are products that
are available without
prescription for self-
treatment of a variety of
complaints.
29
Several problems related to OTC drug use that nurses should consider:
31
Pharmacodynamics
- Is the science dealing with interactions between
the chemical components of living systems and
the foreign chemical, including drugs that enter
the systems.
32
Drug usually work in four ways:
33
Receptor sites
- The receptor sites react with certain chemicals to
cause an effect within the cell.
- The interaction between the chemical and the receptor
site affects enzyme systems within the cell.
- The activated enzyme systems then produce certain
effects, such as increased or decreased cellular
activity, changes in cell membrane permeability, or
alterations in cellular metabolism.
34
35
Pharmacokinetics
Pharmacokinetics
- Involves the study of absorption, distribution,
metabolism, and excretion of the drugs.
Critical Concentration
- The amount of a drug that is needed to cause a
therapeutic effect.
36
Dynamic Equilibrium
- The actual concentration that a drug reaches in the
body results from a dynamic equilibrium involving
several factors:
■ Absorption from the site of entry
■ Distribution to the active site
■ Biotransformation (matabolism) in the liver
■ Excretion from the body
37
Absorption
38
Administration
- Route:
■ IV (Intravenous)
■ IM (Intramuscular)
■ SC (Subcutaneous)
■ PO (oral)
■ PR (rectal)
■ Mucous membranes (sublingual, buccal)
■ Topical (skin)
■ Inhalation
39
Administration
Oral IV IM
Patients can easily Drugs that are injected IV Drugs that are injected IM
continue their drug reach their full strength at are absorbed directly into
regimen at home when the time of injection, the capillaries in the
they are taking oral avoiding initial muscle and sent into
medications. breakdown. circulation.
40
Administration
PR
SC
Uses rectum as a route for
Subcutaneous injections
medication administration which
deposit the drug just under
are absorbed by the rectum’s
the skin, where it slowly
blood vessel and flow into the
absorbed into circulation.
body’s circulatory system which
distributes the drug to the body
system.
41
Administration
42
Distribution
Distribution
- Involves the movement of a Factors affecting the distribution
drug to the body tissues. ▹ Drug’s lipid solubility
▹ Ionization
▹ Perfusion of the reactive tissue
43
Distribution
Blood-Brain Barrier
- The blood brain barrier is a protective system of cellular activity
that keeps foreign invaders, poison, etc away from the CNS.
Placenta and Breast Milk
- Must be given if it outweighs the risk
44
First Pass effect
▸ Oral drugs are absorbed from
the small intestine to Portal
venous system.
▸ With series of liver enzymes,
these enzymes breaks to
metabolites, some activated,
some deactivates and easily
excreted.
▸ Large percentage of the oral
dose is destroyed and never
reaches the tissues
45
Hepatic-enzyme
system
▸ Phase 1: oxidation
reaction
▸ Phase 2: conjugation
reaction
46
Excretion
▸ Removal of drugs from the
body. E.g saliva, lungs, bile,
and feces.
▸ Kidney plays important role -
Glomerular filtration – the
passage of water-soluble
components from plasma to
renal tubules
▸ Others reabsorbed by active
transport system
47
Active transport
48
Half-life
49
Determining the Half-Life
50
51
Factors influencing the
Drug effects
▸ Weight
▸ Age-Pediatric Doses
▸ Gender
▸ Physiologic factors
▸ Pathologic factors
▸ Genetics
▸ Immunologic factors
▸ Psychological factors
52
Factors influencing the
Drug effects
▸ Environmental factors
▸ Drug tolerance
▸ Accumulation effects
▸ Interactions
53
Pediatric Doses
54
Pediatric Doses
55
Pediatric Doses
56
Surface Area Rule
57
Medication Errors !
Nursing Considerations
59
Patient’s Role
60
Patient’s Role
61
Patient’s Role – “Children”
63
Precautions when Reading Drug Labels
64
THANK YOU!
“Develop a passion for learning. If you do, you will
never cease to grow.”
-Anthony D’Angelo, educator
65